Prevalence and determinants of diabetic nephropathy in Korea: Korea National Health and Nutrition examination survey

Diabetes and Metabolism Journal

Volumn 38, Issue 2, 2014, Pages 109-119

  Ahn, Jae Hee ^a   Yu, Ji Hee ^a   Ko, Seung Hyun ^b   Kwon, Hyuk Sang ^b   Kim, Dae Jung ^c   Kim, Jae Hyeon ^d   Kim, Chul Sik ^e   Song, Kee Ho ^f   Won, Jong Chul ^g   Lim, Soo ^h   Choi, Sung Hee ^h   Han, Kyungdo ⁱ   Cha, Bong Yun ^b   Kim, Nan Hee ^a  

^a Korea University College of Medicine   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Hallym University College of Medicine   (South Korea)

^f Konkuk University School of Medicine   (South Korea)

^g Inje University College of Medicine   (South Korea)

^h Seoul National University Bundang Hospital   (South Korea)

ⁱ The Catholic University of Korea   (South Korea)

Author keywords

Albuminuria; Chronic renal disease; Diabetes mellitus; Diabetic nephropathy; Korea

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGE; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; KOREAN (PEOPLE); MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84901494511     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2014.38.2.109     Document Type: Article

References (35)

1. Kidney Disease Improving Global Outcomes. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Chapter 1: definition and classification of CKD. Kidney Int Suppl 2013;3:19-62.
2. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000;160:1093-100.
3. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6.
4. de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, Rifkin DE, Sarnak MJ, Shlipak MG, Siscovick DS. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care 2009;32:1833-8.
5. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1: 1430-2.
6. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 2003;42:617-22.
7. Young BA, Katon WJ, Von Korff M, Simon GE, Lin EH, Ciechanowski PS, Bush T, Oliver M, Ludman EJ, Boyko EJ. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol 2005;16:219-28.
8. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006;69:2057-63.
9. Buck K, Feehally J. Diabetes and renal failure in Indo-Asians in the UK: a paradigm for the study of disease susceptibility. Nephrol Dial Transplant 1997;12:1555-7.
10. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006;17:2275-84.
11. Lee KU, Park JY, Kim SW, Lee MH, Kim GS, Park SK, Park JS. Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care 1995;18:793-9.
12. Park JY, Kim HK, Chung YE, Kim SW, Hong SK, Lee KU. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes. Diabetes Care 1998;21:530-4.
13. Kim ER, Sung KC, Chon CU, Kwon CH, Koh YL, Lee HJ, Park SK, Lee DY, Yun JH, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Ryu SH. Prevalence and clinical characteristics of microal buminuria in Koreans: a population-based cross-sectional study. Korean J Med 2006;70:617-26.
14. Kim DJ, Ryu SJ, Seo YJ, Kim NH, Chung HS, Eun CR, Choi HJ, Kim HS, Yang SJ, Park J, Yoo HJ, Park SY, Lee YJ, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi KM, Baik SH, Choi DS. The prevalence of microalbuminuria and associated factors in newly diagnosed type 2 diabetes mellitus in Korea. Korean J Med 2007;73:503-11.
15. Cho EH, Kim EH, Kim WG, Jeong EH, Koh EH, Lee WJ, Kim MS, Park JY, Lee KU. Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes. Korean Diabetes J 2010;34:200-6.
16. Yang CW, Park JT, Kim YS, Kim YL, Lee YS, Oh YS, Kang SW. Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study). Nephrol Dial Transplant 2011;26:3249-55.
17. Kang HT, Lee J, Linton JA, Park BJ, Lee YJ. Trends in the prevalence of chronic kidney disease in Korean adults: the Korean National Health and Nutrition Examination Survey from 1998 to 2009. Nephrol Dial Transplant 2013;28:927-36.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
19. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003;289:3273-7.
20. Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, Wang W, Zuo Y, Gu H, Xiang K. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant 2009;24: 3724-31.
21. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC. Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 1989;32:870-6.
22. Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, Welborn TA, Atkins RC. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis 2004;44:792-8.
23. Kim YI, Chung YE, Kim JY, Kim SW, Kim ES, Lee MS, Park JY, Hong SK, Lee KU. Microalbuminuria in diabetic and non-diabetic subjects: a population based study. J Korean Diabetes Assoc 1999;23:79-86.
24. Bonnet F, Marre M, Halimi JM, Stengel B, Lange C, Laville M, Tichet J, Balkau B; DESIR Study Group. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 2006;24:1157-63.
25. Chandie Shaw PK, Berger SP, Mallat M, Frolich M, Dekker FW, Rabelink TJ. Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care 2007;30:1840-4.
26. Kramer H, Reboussin D, Bertoni AG, Marcovina S, Lipkin E, Greenway FL 3rd, Brancati FL; Look Ahead Research Group. Obesity and albuminuria among adults with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) Study. Diabetes Care 2009;32:851-3.
27. Lee JE, Huh W, Son HJ, Kim YG, Kim DJ, Lee MK, Oh HY. Association of metabolic syndrome with microalbuminuria in non-hypertensive type 2 diabetic patients. Nephron Clin Pract 2007;106:c98-103.
28. Wentworth JM, Fourlanos S, Colman PG. Body mass index correlates with ischemic heart disease and albuminuria in long-standing type 2 diabetes. Diabetes Res Clin Pract 2012;97:57-62.
29. Lee SW, Kim YC, Oh SW, Koo HS, Na KY, Chae DW, Kim S, Chin HJ. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 2011;26:3975-80.
30. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011;305:2532-9.
31. Chen W, Chen W, Wang H, Dong X, Liu Q, Mao H, Tan J, Lin J, Zhou F, Luo N, He H, Johnson RJ, Zhou SF, Yu X. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant 2009;24:1205-12.
32. Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M; Japan Diabetes Clinical Data Management Study Group. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2009;24:1212-9.
33. Mulec H, Johnsen SA, Wiklund O, Bjorck S. Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 1993; 22:196-201.
34. Vaziri ND, Moradi H. Mechanisms of dyslipidemia of chronic renal failure. Hemodial Int 2006;10:1-7.
35. Reutens AT. Epidemiology of diabetic kidney disease. Med Clin North Am 2013; 97:1-18.